Evaluation of the Prevalence and Potential Impact of HPV Vaccines in Patients with and Without Oral Diseases: A Ten-Year Retrospective Study
This study provided new insights into the prevalence of oral HPV and showed that the nonavalent vaccine may provide better protection than the other vaccines in the presence of an OSCC diagnosis. Conversely, the quadrivalent vaccine may be sufficient to prevent OPMD and BL.
Authors
- Nicola Serra (ORCID: https://orcid.org/0000-0001-8086-6362)
- Daniela Cabibi (ORCID: https://orcid.org/0000-0001-6571-6577)
- Michela Buttà (ORCID: https://orcid.org/0000-0002-2410-8759)
- Daniela Pistoia
- Vera Panzarella (ORCID: https://orcid.org/0000-0001-6339-6020)
- Giuseppina Capra (ORCID: https://orcid.org/0000-0002-1407-7282)
- Giuseppina Campisi (ORCID: https://orcid.org/0000-0002-9443-0495)
- Erika Mannino
Institutions
- Department of Health (ES)
- Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT)
- University of Naples Federico II (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Archives of Medical Research
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1016/j.arcmed.2024.103059
- Citations
- 7
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Università degli Studi di Palermo